China's U-turn in its COVID-19 policy.
作者信息
Wilson Olwen, Flahault Antoine
机构信息
Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; School of Public Policy, London School of Economics, London, UK.
Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
出版信息
Anaesth Crit Care Pain Med. 2023 Apr;42(2):101197. doi: 10.1016/j.accpm.2023.101197. Epub 2023 Jan 13.
Abstract
摘要
相似文献
1
China's U-turn in its COVID-19 policy.
Anaesth Crit Care Pain Med. 2023 Apr;42(2):101197. doi: 10.1016/j.accpm.2023.101197. Epub 2023 Jan 13.
2
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345.
3
Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
J Infect. 2022 Jul;85(1):e7-e9. doi: 10.1016/j.jinf.2022.04.044. Epub 2022 May 1.
4
Peritraumatic distress and psychological symptoms in people infected with COVID-19 after the easing of "China's zero-COVID policy".
Psychiatry Clin Neurosci. 2023 Aug;77(8):457-458. doi: 10.1111/pcn.13559. Epub 2023 Jun 1.
5
An equitable route forward from China's 'zero COVID' policy.
Nat Med. 2023 Mar;29(3):514-515. doi: 10.1038/d41591-023-00002-0.
6
A sequential re-opening of provinces for China's zero-COVID policy.
Nat Med. 2023 Dec;29(12):2977-2978. doi: 10.1038/s41591-022-02177-4.
7
Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy.
Front Public Health. 2023 May 9;11:1099116. doi: 10.3389/fpubh.2023.1099116. eCollection 2023.
8
Evaluation of China's public health system response to COVID-19.
J Glob Health. 2021 Jan 16;11:05004. doi: 10.7189/jogh.11.05004.
9
Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
Glob Public Health. 2021 Aug-Sep;16(8-9):1223-1236. doi: 10.1080/17441692.2021.1919735. Epub 2021 Apr 23.
10
Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
Front Public Health. 2021 Apr 23;9:610824. doi: 10.3389/fpubh.2021.610824. eCollection 2021.
引用本文的文献
1
Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China's Zero-COVID policy: results from a web-based survey.
Front Pharmacol. 2025 May 12;16:1524068. doi: 10.3389/fphar.2025.1524068. eCollection 2025.
2
Factors Influencing the Use and Demand of New Coronavirus Therapy Drugs Among the Adults During COVID-19 in China.
Risk Manag Healthc Policy. 2024 Aug 8;17:1937-1945. doi: 10.2147/RMHP.S468700. eCollection 2024.
3
Impact on hospitalization and infection patterns of advanced lung cancer with lower respiratory tract infections: Targeted therapy vs. chemoradiotherapy.
Oncol Lett. 2024 Feb 14;27(4):154. doi: 10.3892/ol.2024.14287. eCollection 2024 Apr.
4
Factors Influencing the Behavioral Intentions and Use Behaviors of Telemedicine in Patients With Diabetes: Web-Based Survey Study.
JMIR Hum Factors. 2023 Dec 28;10:e46624. doi: 10.2196/46624.
5
Was China's zero-COVID policy the right choice? The multiple factor analysis of variables that affected the course of COVID-19 pandemic in China.
Front Public Health. 2023 Dec 6;11:1252370. doi: 10.3389/fpubh.2023.1252370. eCollection 2023.
6
The impact of Chinese COVID-19 pandemic on the incidence of peripheral facial nerve paralysis after optimizing policies.
Front Public Health. 2023 Nov 2;11:1236985. doi: 10.3389/fpubh.2023.1236985. eCollection 2023.
7
Trajectory analysis of the work and life experience of healthcare workers during the COVID-19 pandemic: a longitudinal qualitative study.
BMC Nurs. 2023 Sep 27;22(1):333. doi: 10.1186/s12912-023-01520-5.
8
The relationship between sublingual immunotherapy for allergic rhinitis and the risk of symptoms in patients with COVID-19 infection.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2236538. doi: 10.1080/21645515.2023.2236538.
Zotero 插件